Sino Biopharmaceutical Limited
SBMFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,499,834 | $5,933,579 | $5,778,604 | $18,572,673 |
| Dep. & Amort. | $1,321,181 | $1,074,284 | $1,046,984 | $992,556 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $53,721 | $18,123 | $29,723 | $0 |
| Change in WC | $27,096 | -$430,514 | -$195,595 | -$339,135 |
| Other Non-Cash | $1,713,288 | -$529,738 | -$394,561 | -$13,859,800 |
| Operating Cash Flow | $6,615,120 | $6,065,734 | $6,265,155 | $5,366,294 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,067,823 | -$1,705,612 | -$1,893,984 |
| Net Acquisitions | $0 | -$742,706 | -$58,525 | -$958,703 |
| Inv. Purchases | $0 | -$1,650,007 | -$4,482,997 | -$4,846,666 |
| Inv. Sales/Matur. | $0 | $2,561,471 | $1,079,023 | $903,244 |
| Other Inv. Act. | -$1,709,126 | $142,090 | $1,097,292 | $4,280,132 |
| Investing Cash Flow | -$1,709,126 | -$756,975 | -$4,070,819 | -$2,515,977 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,779,267 | -$1,753,743 | $1,049,125 | -$1,637,608 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,252,200 | -$396,393 | -$867,613 | -$332,930 |
| Dividends Paid | -$1,846,381 | -$632,669 | -$1,267,622 | -$938,489 |
| Other Fin. Act. | -$437,238 | -$3,766,185 | -$2,100,280 | -$316,236 |
| Financing Cash Flow | -$6,315,086 | -$6,548,990 | -$3,186,390 | -$3,225,263 |
| Forex Effect | $135,517 | $90,524 | $47,322 | -$649,711 |
| Net Chg. in Cash | -$1,273,575 | -$1,149,707 | -$944,732 | -$1,024,657 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,505,098 | $8,654,805 | $9,599,537 | $10,624,194 |
| End Cash | $6,231,523 | $7,505,098 | $8,654,805 | $9,599,537 |
| Free Cash Flow | $5,655,018 | $4,362,025 | $4,559,543 | $3,472,310 |